Q32 Bio (QTTB) Net Income towards Common Stockholders (2018 - 2025)
Historic Net Income towards Common Stockholders for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to -$7.4 million.
- Q32 Bio's Net Income towards Common Stockholders rose 5800.51% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 19405.73%. This contributed to the annual value of -$63533.0 for FY2024, which is 1821.63% down from last year.
- As of Q3 2025, Q32 Bio's Net Income towards Common Stockholders stood at -$7.4 million, which was up 5800.51% from -$9.5 million recorded in Q2 2025.
- In the past 5 years, Q32 Bio's Net Income towards Common Stockholders registered a high of $92.7 million during Q1 2022, and its lowest value of -$34.6 million during Q4 2022.
- In the last 5 years, Q32 Bio's Net Income towards Common Stockholders had a median value of -$14.0 million in 2023 and averaged -$6.6 million.
- Per our database at Business Quant, Q32 Bio's Net Income towards Common Stockholders soared by 873588.07% in 2022 and then tumbled by 19237.13% in 2024.
- Over the past 5 years, Q32 Bio's Net Income towards Common Stockholders (Quarter) stood at -$33.6 million in 2021, then dropped by 2.94% to -$34.6 million in 2022, then skyrocketed by 177.01% to $26.6 million in 2023, then soared by 85.11% to $49.3 million in 2024, then tumbled by 114.99% to -$7.4 million in 2025.
- Its Net Income towards Common Stockholders stands at -$7.4 million for Q3 2025, versus -$9.5 million for Q2 2025 and -$11.0 million for Q1 2025.